← FDA Drug Approvals (Drugs@FDA)

ORPHENADRINE CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 1982-06-29

Drug application

FDA Application #

ANDA085046

Application type

Abbreviated New Drug Application (Generic)

Brand name

ORPHENADRINE CITRATE

Generic name

Orphenadrine Citrate

Active ingredients

ORPHENADRINE CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

SANDOZ

First approval

1982-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown